|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | September 18, 2002 | ||||||||
| Last Updated Date | August 24, 2009 | ||||||||
| Start Date ICMJE | February 2000 | ||||||||
| Estimated Primary Completion Date | January 2005 (final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures ICMJE | |||||||||
| Original Primary Outcome Measures ICMJE | |||||||||
| Change History | Complete list of historical versions of study NCT00046059 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE | |||||||||
| Original Secondary Outcome Measures ICMJE | |||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) | ||||||||
| Official Title ICMJE | Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) | ||||||||
| Brief Summary | Attention Deficit Hyperactivity Disorder (ADHD) is the most common behavioral disorder in childhood, affecting 3-5% of children between the ages of 7 and 17. Family studies suggest that there is a genetic component to ADHD. Scientists believe that it is a complex disorder in which two or more genes may be involved. Potentially eligible families will be asked to give written consent to participate and will be asked to complete questionnaires for each member in the family. In addition, an interview will be administered to the parent of minors enrolled in the study to determine their eligibility for being in the study. This screening tool is computerized and will take approximately 45 minutes to administer per child. Once screenings are completed, a blood collection kit will be sent to the family to take to their local medical care provider, have blood samples drawn and sent to NIH. There is no cost to the family to participate. We would like to enroll entire families, with both parents and all children. |
||||||||
| Detailed Description | A study of the hypothesis that Attention Deficit Hyperactivity Disorder (ADHD) is a genetically influenced brain disorder has been undertaken using a two armed approach: 1) a large, extended pedigree study done in Columbia, South America in a population isolate called the Paisa; and 2) a U.S. based study with at least one affected child and at least one sibling (either affected or unaffected), and their parents. Following careful phenotyping, DNA from blood samples from these two groups will be analyzed through a genome-wide scan for linkage and positional candidate approach to search for genes associated with ADHD. The prefrontal cortex is known to play a very important role in the processing of emotions and impulsivity. Measurement of brain metabolites in this region may be very useful in phenotyping ADHD. Thus, in the Columbian population, in a subset of already recruited individuals, phenotyping will include proton magnetic resonance spectroscopy (H MRS) to detect biochemical phenotypes which may be correlated with genetic markers for ADHD. |
||||||||
| Study Phase | |||||||||
| Study Type ICMJE | Observational | ||||||||
| Study Design ICMJE | |||||||||
| Condition ICMJE | Attention Deficit Disorder With Hyperactivity | ||||||||
| Intervention ICMJE | |||||||||
| Study Arms / Comparison Groups | |||||||||
| Publications * |
|
||||||||
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Recruiting | ||||||||
| Enrollment ICMJE | 4000 | ||||||||
| Completion Date | |||||||||
| Estimated Primary Completion Date | January 2005 (final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria ICMJE |
For both the U.S. and the Columbian Studies, we plan to obtain blood samples from subjects meeting the following criteria: Children , ages 7-17, affected with ADHD with siblings who are either affected or unaffected, and their parents. (in the Columbian Study, we will also gather information and blood samples from extended families). Adult participants 18 years or older selected for MRS from the Paisa population will be included if they:
|
||||||||
| Gender | Both | ||||||||
| Ages | 7 Years and older | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE |
|
||||||||
| Location Countries ICMJE | United States, Colombia | ||||||||
| Administrative Information | |||||||||
| NCT ID ICMJE | NCT00046059 | ||||||||
| Responsible Party | |||||||||
| Study ID Numbers ICMJE | 000058, 00-HG-0058 | ||||||||
| Study Sponsor ICMJE | National Human Genome Research Institute (NHGRI) | ||||||||
| Collaborators ICMJE | |||||||||
| Investigators ICMJE | |||||||||
| Information Provided By | National Institutes of Health Clinical Center (CC) | ||||||||
| Verification Date | January 2009 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||